Drug Controller General of India Approves Trials Of Favipiravir Against COVID-19

Drug Controller General of India has approved clinical trials of Favipiravir which is used against influenza and could be potentially useful against COVID-19 as a phytopharmaceutical which is a plant: CSIR Director General Shekhar Mande